Earlier this month,The Food and Drug Administration (FDA) announced that testing indicated the presence of asbestos in three of retailer Claire’s cosmetics products, according to a statement issued by FDA Commissioner Scott Gottlieb, M.D., and Susan Mayne, Ph.D., director of the Centre for Food Safety and Applied Nutrition.
The controversy surrounding the products started back in 2017, when a local newspaper report claimed that a mother from Rhode Island, decided to have her daughter’s Claire’s makeup tested for asbestos. The test reportedly came back positive and the family decided to independently test even more products which also came back positive for asbestos.
Claire’s has denied the presence of asbestos in any of its products. In 2017. the company stated that its internal test results were negative for asbestos, but it recalled several products as a cautionary measure in 2017.
Further tests were carried out by a third-party, which indicated that three of Claire’s products contained asbestos, but the company still robustly denied the test results in a statement last year.After those reports, the FDA took the decision to carry out its own testing, the results of which were finally revealed this month.
After Claire’s withdrew suspect products from the market, the FDA began the process of conducting independent tests to determine if some of these products did in fact contain asbestos,” the statement says. “In late February of this year, we received the results of this testing initiative.”
Specifically, the FDA’s testing found tremolite asbestos in three Claire’s products:
Claire’s Eye Shadows – Batch No/Lot No: 08/17
Claire’s Compact Powder – Batch No/Lot No: 07/15
Claire’s Contour Palette – Batch No/Lot No: 04/17